甲状腺未分化癌驱动基因与免疫检查点数据集

甲状腺未分化癌(ATC)基因表达数据集,包含75例正常和169例甲状腺癌样本,通过WGCNA识别驱动基因和免疫检查点。

NIAID Data Ecosystem
浏览 22
表格anaplastic thyroid carcinomaenrichment analysistranscription factorimmune checkpointtherapeutic target
Table_9_Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint identification for therapeutic targets.xls

基本信息

模态
表格
大小
0.00005888 GB
许可
CC BY 4.0
创建/更新时间
2026-10-08
版本
v1

资源简介

甲状腺未分化癌驱动基因与免疫检查点数据集

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 58.88 KB,主题涵盖 anaplastic thyroid carcinoma、enrichment analysis、transcription factor、immune checkpoint、therapeutic target,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Table_9_Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint identification for therapeutic targets.xls》。配套论文《Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies》发表于 Nature Reviews Endocrinology(2017),DOI:10.1038/nrendo.2017.76。源站首次发布:2022-12-01。

【数据内容】

源站原始描述:BackgroundAnaplastic thyroid carcinoma (ATC) is a rare but extremely malignant tumor, with a rapid growth rate and early metastasis thus leading to poor survival of patients. The molecular mechanisms underlying these aggressive traits of ATC remain unknown, which impedes the substantial progress in treatment to prolong ATC patient survival. MethodsWe applied weighted gene co-expression network analysis (WGCNA) to identify ATC-specific modules. The Metascape web and R package clusterProfiler were…

【数据结构与技术规格】

文件数 1 个,合计 58.88 KB。Table_9_Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint iden.xls:application/vnd.ms-excel,58.88 KB。数据集 DOI:10.3389/fonc.2022.1018479.s011。

【主题与分类】

源站学科分类:Cancer、Haematological Tumours、Molecular Targets、Radiation Therapy、Oncology and Carcinogenesis not elsewhere classified、Solid Tumours。主题标签:anaplastic thyroid carcinoma、enrichment analysis、transcription factor、immune checkpoint、therapeutic target。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/Table_9_Weighted_gene_co-expression_network_reveals_driver_genes_contributing_to_phenotypes_of_anaplastic_thyroid_carcinoma_and_immune_checkpoint_identification_for_therapeutic_targets_xls/21653492

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Dong, Xingxing; Yang, Yalong; Hou, Jinxuan; Chen, Weizhen; Yuan, Qianqian; Xu, Gaoran; et al. (2022). Table_9_Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint identification for therapeutic targets.xls. Frontier…

【使用注意】

· 源站最后修改于 2023-06-21,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Table_9_Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint iden.xls" "https://ndownloader.figshare.com/files/38390423"

文件清单

  • Table_9_Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint iden.xls(58.88 KB)

文件总体积 58.88 KB(源站 API 实测)。

数据说明

BackgroundAnaplastic thyroid carcinoma (ATC) is a rare but extremely malignant tumor, with a rapid growth rate and early metastasis thus leading to poor survival of patients. The molecular mechanisms underlying these aggressive traits of ATC remain unknown, which impedes the substantial progress in treatment to prolong ATC patient survival.
MethodsWe applied weighted gene co-expression network analysis (WGCNA) to identify ATC-specific modules. The Metascape web and R package clusterProfiler were employed to perform enrichment analysis. Combined with differentially expressed gene analysis, we screened out the most potential driver genes and validated them using receiver operator characteristic (ROC) analysis, quantitative reverse transcription polymerase chain reaction (qRT-PCR), western blotting, immunohistochemistry (IHC), and triple immunofluorescence staining.
ResultsA gene expression matrix covering 75 normal samples, 83 papillary thyroid carcinoma (PTC), 26 follicular thyroid carcinoma (FTC), 19 poor-differentiated thyroid carcinoma (PDTC), and 41 ATC tissue samples were integrated, based on which we detected three most potential ATC-specific modules and found that hub genes of these modules were enriched in distinct biological signals. Hub genes in the turquoise module were mainly enriched in mitotic cell cycle, tube morphogenesis, and cell differentiation, hub genes in the magenta module were mainly clustered in the extracellular matrix organization, positive regulation of cell motility, and regulation of Wnt signaling pathway, while hub genes in the blue module primarily participated in the inflammatory response, innate immune response, and adaptive immune response. We showed that 9 top genes, 8 transcription factors (TFs), and 4 immune checkpoint genes (ICGs) were differentially expressed in ATC compared to other thyroid samples and had high diagnostic values for ATC, among which, 9 novel ATC-specific genes (ADAM12, RNASE2, CASP5, KIAA1524, E2F7, MYBL1, SRPX2, HAVCR2, and TDO2) were validated with our clinical samples. Furthermore, we illustrated that ADAM12, RNASE2, and HAVCR2 were predominantly present in the cytoplasm.
ConclusionOur study identified

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fonc.2022.1018479.s011(source: https://frontiersin.figshare.com/articles/dataset/Table_9_Weighted_gene_co-expression_network_reveals_driver_genes_contributing_to_phenotypes_of_anaplastic_thyroid_carcinoma_and_immune_checkpoint_identification_for_therapeutic_targets_xls/21653492)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案